<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="interaction" /><meta name="keywords" content="" /><title>Histamine H2-antagonists: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="bnf_int743-histamine-h-2-antagonists.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="bnf_int743-histamine-h-2-antagonists.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=bnf_int743-histamine-h-2-antagonists.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 07 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP8848-interactions.htm">Appendix 1 Interactions</a> &gt; <a href="PHP8852-list-of-drug-interactions.htm">List of drug interactions</a> &gt; <a href="bnf_int741-ulcer-healing-drugs.htm">Ulcer-healing Drugs</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="bnf_int741-ulcer-healing-drugs.htm" title="Previous: Ulcer-healing Drugs">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="bnf_int744-cimetidine.htm" title="Next: Cimetidine">Next page</a> ►</div></div></div></div><div id="p1"><div id="pB"><h1>Histamine H<sub>2</sub>-antagonists</h1><?highlighter on?><div id="pC" class="jN"><p><strong>Histamine H<sub>2</sub>-antagonists</strong> has the following interaction information:</p><table summary="Drug interactions" width="100%" border="0" cellspacing="2"><colgroup><col width="30%" class="cAG" /><col width="40%" class="cAF" /><col width="30%" class="cAH" /></colgroup><tbody><tr><td><a href="bnf_int1005-atazanavir.htm">Atazanavir</a></td><td class="cAI"><p><span></span> <span>histamine H<sub>2</sub>-antagonists</span> <span>reduce plasma concentration of</span> <span>atazanavir</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int148-cefpodoxime.htm">Cefpodoxime</a></td><td><p><span></span> <span>histamine H<sub>2</sub>-antagonists</span> <span>reduce absorption of</span> <span>cefpodoxime</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int1180-histamine.htm">Histamine</a></td><td><p><span></span> <span>histamine H<sub>2</sub>-antagonists</span> <span>theoretically antagonise effects of</span> <span>histamine</span> <span>—manufacturer of <span>histamine</span> advises avoid concomitant use</span>  </p></td><td></td></tr><tr><td><a href="bnf_int302-itraconazole.htm">Itraconazole</a></td><td><p><span></span> <span>histamine H<sub>2</sub>-antagonists</span> <span>reduce absorption of</span> <span>itraconazole</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int298-ketoconazole.htm">Ketoconazole</a></td><td><p><span></span> <span>histamine H<sub>2</sub>-antagonists</span> <span>reduce absorption of</span> <span>ketoconazole</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int1128-lapatinib.htm">Lapatinib</a></td><td><p><span></span> <span>histamine H<sub>2</sub>-antagonists</span> <span>possibly reduce absorption of</span> <span>lapatinib</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int1060-posaconazole.htm">Posaconazole</a></td><td><p><span>avoidance of </span> <span>histamine H<sub>2</sub>-antagonists</span> <span>advised by manufacturer of</span> <span>posaconazole</span> <span>(plasma concentration of <span>posaconazole</span> possibly reduced)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int1111-raltegravir.htm">Raltegravir</a></td><td><p><span></span> <span>histamine H<sub>2</sub>-antagonists</span> <span>possibly increase plasma concentration of</span> <span>raltegravir</span> <span>—manufacturer of <span>raltegravir</span> advises avoid concomitant use</span>  </p></td><td></td></tr><tr><td><a href="bnf_int1225-rilpivirine.htm">Rilpivirine</a></td><td><p><span>avoidance of </span> <span>histamine H<sub>2</sub>-antagonists</span> <span>for 12 hours before or 4 hours after</span> <span>rilpivirine</span> <span>advised by manufacturer of <span>rilpivirine</span>—consult product literature</span>  </p></td><td></td></tr><tr><td><a href="bnf_int1163-ulipristal.htm">Ulipristal</a></td><td class="cAI"><p><span>avoidance of </span> <span>histamine H<sub>2</sub>-antagonists</span> <span>advised by manufacturer of</span> <span>ulipristal</span> <span>(plasma concentration of <span>ulipristal</span> possibly reduced)</span>  </p></td><td></td></tr></tbody></table><p><strong>Histamine H<sub>2</sub>-antagonists</strong> belongs to <strong>Ulcer-healing Drugs</strong> but <strong>Ulcer-healing Drugs</strong> has no interactions information.</p><p><strong>Cimetidine</strong> belongs to <strong>Histamine H<sub>2</sub>-antagonists</strong> and has the following interaction information:</p><table summary="Drug interactions" width="100%" border="0" cellspacing="2"><colgroup><col width="30%" class="cAG" /><col width="40%" class="cAF" /><col width="30%" class="cAH" /></colgroup><tbody><tr><td><a href="bnf_int118-amiodarone.htm">Amiodarone</a></td><td><p><span></span> <span>cimetidine</span> <span>increases plasma concentration of</span> <span>amiodarone</span> <span></span>  </p></td><td><div class="cG"><p><strong>Note:</strong> Amiodarone has a long half-life; there is a potential for drug interactions to occur for several weeks (or even months) after treatment with it has been stopped</p></div></td></tr><tr><td><a href="bnf_int242-amitriptyline.htm">Amitriptyline</a></td><td><p><span></span> <span>cimetidine</span> <span>inhibits metabolism of</span> <span>amitriptyline</span> <span>(increased plasma concentration)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int241-antidepressants-tricyclic.htm">Antidepressants, Tricyclic</a></td><td><p><span></span> <span>cimetidine</span> <span>possibly increases plasma concentration of</span> <span>tricyclics</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int363-antipsychotics.htm">Antipsychotics</a></td><td><p><span></span> <span>cimetidine</span> <span>possibly enhances effects of</span> <span>antipsychotics</span> <span></span>  </p></td><td><div class="cG"><p><strong>Note:</strong> Increased risk of toxicity with myelosuppressive drugs</p></div></td></tr><tr><td><a href="bnf_int937-artemether-with-lumefantrine.htm">Artemether with Lumefantrine</a></td><td class="cAI"><p><span>avoidance of </span> <span>cimetidine</span> <span>advised by manufacturer of</span> <span>artemether/lumefantrine</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int405-benzodiazepines.htm">Benzodiazepines</a></td><td><p><span></span> <span>cimetidine</span> <span>inhibits metabolism of</span> <span>benzodiazepines</span> <span>(increased plasma concentration)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int466-calcium-channel-blockers.htm">Calcium-channel Blockers</a></td><td><p><span></span> <span>cimetidine</span> <span>possibly inhibits metabolism of</span> <span>calcium-channel blockers</span> <span>(increased plasma concentration)</span>  </p></td><td><div class="cG"><p><strong>Note:</strong> Dihydropyridine calcium-channel blockers include amlodipine, felodipine, isradipine, lacidipine, lercanidipine, nicardipine, nifedipine, and nimodipine</p></div></td></tr><tr><td><a href="bnf_int277-carbamazepine.htm">Carbamazepine</a></td><td class="cAI"><p><span></span> <span>cimetidine</span> <span>inhibits metabolism of</span> <span>carbamazepine</span> <span>(increased plasma concentration)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int1123-carmustine.htm">Carmustine</a></td><td><p><span></span> <span>cimetidine</span> <span>possibly enhances myelosuppressive effects of</span> <span>carmustine</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int335-chloroquine-and-hydroxychloroquine.htm">Chloroquine and Hydroxychloroquine</a></td><td><p><span></span> <span>cimetidine</span> <span>inhibits metabolism of</span> <span>chloroquine and hydroxychloroquine</span> <span>(increased plasma concentration)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int374-chlorpromazine.htm">Chlorpromazine</a></td><td><p><span></span> <span>cimetidine</span> <span>possibly enhances effects of</span> <span>chlorpromazine</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int499-ciclosporin.htm">Ciclosporin</a></td><td class="cAI"><p><span></span> <span>cimetidine</span> <span>possibly increases plasma concentration of</span> <span>ciclosporin</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int233-citalopram.htm">Citalopram</a></td><td><p><span></span> <span>cimetidine</span> <span>increases plasma concentration of</span> <span>citalopram</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int423-clomethiazole.htm">Clomethiazole</a></td><td><p><span></span> <span>cimetidine</span> <span>inhibits metabolism of</span> <span>clomethiazole</span> <span>(increased plasma concentration)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int865-clopidogrel.htm">Clopidogrel</a></td><td class="cAI"><p><span></span> <span>cimetidine</span> <span>possibly reduces antiplatelet effect of</span> <span>clopidogrel</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int364-clozapine.htm">Clozapine</a></td><td><p><span></span> <span>cimetidine</span> <span>possibly enhances effects of</span> <span>clozapine</span> <span></span>  </p></td><td><div class="cG"><p><strong>Note:</strong> Avoid concomitant use of clozapine with drugs that have a substantial potential for causing agranulocytosis</p></div></td></tr><tr><td><a href="bnf_int220-coumarins.htm">Coumarins</a></td><td class="cAI"><p><span></span> <span>cimetidine</span> <span>inhibits metabolism of</span> <span>coumarins</span> <span>(enhanced anticoagulant effect)</span>  </p></td><td><div class="cG"><p><strong>Note:</strong> Change in patient's clinical condition, particularly associated with liver disease, intercurrent illness, or drug administration, necessitates more frequent testing. Major changes in diet (especially involving salads and vegetables) and in alcohol consumption may also affect anticoagulant control</p></div></td></tr><tr><td><a href="bnf_int246-doxepin.htm">Doxepin</a></td><td><p><span></span> <span>cimetidine</span> <span>inhibits metabolism of</span> <span>doxepin</span> <span>(increased plasma concentration)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int1030-epirubicin.htm">Epirubicin</a></td><td class="cAI"><p><span></span> <span>cimetidine</span> <span>increases plasma concentration of</span> <span>epirubicin</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int563-ergotamine-and-methysergide.htm">Ergotamine and Methysergide</a></td><td class="cAI"><p><span>increased risk of ergotism when </span> <span>cimetidine</span> <span>given with</span> <span>ergotamine and methysergide</span> <span>—avoid concomitant use</span>  </p></td><td></td></tr><tr><td><a href="bnf_int1048-erlotinib.htm">Erlotinib</a></td><td class="cAI"><p><span>avoidance of </span> <span>cimetidine</span> <span>advised by manufacturer of</span> <span>erlotinib</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int169-erythromycin.htm">Erythromycin</a></td><td><p><span></span> <span>cimetidine</span> <span>increases plasma concentration of</span> <span>erythromycin</span> <span>(increased risk of toxicity, including deafness)</span>  </p></td><td><div class="cG"><p><strong>Note:</strong> Interactions do not apply to small amounts of erythromycin used topically</p></div></td></tr><tr><td><a href="bnf_int964-escitalopram.htm">Escitalopram</a></td><td><p><span></span> <span>cimetidine</span> <span>increases plasma concentration of</span> <span>escitalopram</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int1220-fampridine.htm">Fampridine</a></td><td class="cAI"><p><span>avoidance of </span> <span>cimetidine</span> <span>advised by manufacturer of</span> <span>fampridine</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int120-flecainide.htm">Flecainide</a></td><td><p><span></span> <span>cimetidine</span> <span>inhibits metabolism of</span> <span>flecainide</span> <span>(increased plasma concentration)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int509-fluorouracil.htm">Fluorouracil</a></td><td><p><span></span> <span>cimetidine</span> <span>inhibits metabolism of</span> <span>fluorouracil</span> <span>(increased plasma concentration)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int247-imipramine.htm">Imipramine</a></td><td><p><span></span> <span>cimetidine</span> <span>inhibits metabolism of</span> <span>imipramine</span> <span>(increased plasma concentration)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int472-isradipine.htm">Isradipine</a></td><td><p><span></span> <span>cimetidine</span> <span>increases plasma concentration of</span> <span>isradipine</span> <span>(halve dose of <span>isradipine</span>)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int448-labetalol.htm">Labetalol</a></td><td><p><span></span> <span>cimetidine</span> <span>increases plasma concentration of</span> <span>labetalol</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int738-levothyroxine.htm">Levothyroxine</a></td><td><p><span></span> <span>cimetidine</span> <span>reduces absorption of</span> <span>levothyroxine</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int55-lidocaine.htm">Lidocaine</a></td><td class="cAI"><p><span></span> <span>cimetidine</span> <span>increases plasma concentration of</span> <span>lidocaine</span> <span>(increased risk of toxicity)</span>  </p></td><td><div class="cG"><p><strong>Note:</strong> Interactions less likely when lidocaine used topically</p></div></td></tr><tr><td><a href="bnf_int1122-lomustine.htm">Lomustine</a></td><td><p><span></span> <span>cimetidine</span> <span>possibly enhances myelosuppressive effects of</span> <span>lomustine</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int309-loratadine.htm">Loratadine</a></td><td><p><span>manufacturer of loratadine advises </span> <span>cimetidine</span> <span>possibly increases plasma concentration of</span> <span>loratadine</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int609-mebendazole.htm">Mebendazole</a></td><td><p><span></span> <span>cimetidine</span> <span>possibly inhibits metabolism of</span> <span>mebendazole</span> <span>(increased plasma concentration)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int1114-melatonin.htm">Melatonin</a></td><td><p><span></span> <span>cimetidine</span> <span>increases plasma concentration of</span> <span>melatonin</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int267-metformin.htm">Metformin</a></td><td><p><span></span> <span>cimetidine</span> <span>reduces excretion of</span> <span>metformin</span> <span>(increased plasma concentration)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int451-metoprolol.htm">Metoprolol</a></td><td><p><span></span> <span>cimetidine</span> <span>increases plasma concentration of</span> <span>metoprolol</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int170-metronidazole.htm">Metronidazole</a></td><td><p><span></span> <span>cimetidine</span> <span>inhibits metabolism of</span> <span>metronidazole</span> <span>(increased plasma concentration)</span>  </p></td><td><div class="cG"><p><strong>Note:</strong> Interactions do not apply to topical metronidazole preparations </p></div></td></tr><tr><td><a href="bnf_int823-mirtazapine.htm">Mirtazapine</a></td><td><p><span></span> <span>cimetidine</span> <span>increases plasma concentration of</span> <span>mirtazapine</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int262-moclobemide.htm">Moclobemide</a></td><td><p><span></span> <span>cimetidine</span> <span>increases plasma concentration of</span> <span>moclobemide</span> <span>(halve dose of <span>moclobemide</span>)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int249-nortriptyline.htm">Nortriptyline</a></td><td><p><span></span> <span>cimetidine</span> <span>inhibits metabolism of</span> <span>nortriptyline</span> <span>(increased plasma concentration)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int584-octreotide.htm">Octreotide</a></td><td><p><span>absorption of </span> <span>cimetidine</span> <span>possibly delayed by</span> <span>octreotide</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int85-opioid-analgesics.htm">Opioid Analgesics</a></td><td><p><span></span> <span>cimetidine</span> <span>inhibits metabolism of</span> <span>opioid analgesics</span> <span>(increased plasma concentration)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int284-phenytoin.htm">Phenytoin</a></td><td class="cAI"><p><span></span> <span>cimetidine</span> <span>inhibits metabolism of</span> <span>phenytoin</span> <span>(increased plasma concentration)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int1060-posaconazole.htm">Posaconazole</a></td><td class="cAI"><p><span></span> <span>cimetidine</span> <span>reduces plasma concentration of</span> <span>posaconazole</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int881-pramipexole.htm">Pramipexole</a></td><td><p><span></span> <span>cimetidine</span> <span>reduces excretion of</span> <span>pramipexole</span> <span>(increased plasma concentration)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int125-propafenone.htm">Propafenone</a></td><td class="cAI"><p><span></span> <span>cimetidine</span> <span>increases plasma concentration of</span> <span>propafenone</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int793-propranolol.htm">Propranolol</a></td><td><p><span></span> <span>cimetidine</span> <span>increases plasma concentration of</span> <span>propranolol</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int341-quinine.htm">Quinine</a></td><td><p><span></span> <span>cimetidine</span> <span>inhibits metabolism of</span> <span>quinine</span> <span>(increased plasma concentration)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int201-rifampicin.htm">Rifampicin</a></td><td><p><span>metabolism of </span> <span>cimetidine</span> <span>accelerated by</span> <span>rifampicin</span> <span>(reduced plasma concentration)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int1190-roflumilast.htm">Roflumilast</a></td><td><p><span></span> <span>cimetidine</span> <span>inhibits the metabolism of</span> <span>roflumilast</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int791-saquinavir.htm">Saquinavir</a></td><td><p><span></span> <span>cimetidine</span> <span>possibly increases plasma concentration of</span> <span>saquinavir</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int237-sertraline.htm">Sertraline</a></td><td><p><span></span> <span>cimetidine</span> <span>increases plasma concentration of</span> <span>sertraline</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int858-sildenafil.htm">Sildenafil</a></td><td><p><span></span> <span>cimetidine</span> <span>increases plasma concentration of</span> <span>sildenafil</span> <span>(consider reducing dose of <span>sildenafil</span>)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int268-sulfonylureas.htm">Sulfonylureas</a></td><td><p><span></span> <span>cimetidine</span> <span>enhances hypoglycaemic effect of</span> <span>sulfonylureas</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int292-terbinafine.htm">Terbinafine</a></td><td><p><span></span> <span>cimetidine</span> <span>increases plasma concentration of</span> <span>terbinafine</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int734-theophylline.htm">Theophylline</a></td><td class="cAI"><p><span></span> <span>cimetidine</span> <span>inhibits metabolism of</span> <span>theophylline</span> <span>(increased plasma concentration)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int1027-tolazoline.htm">Tolazoline</a></td><td class="cAI"><p><span></span> <span>cimetidine</span> <span>antagonises effects of</span> <span>tolazoline</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int286-valproate.htm">Valproate</a></td><td class="cAI"><p><span></span> <span>cimetidine</span> <span>inhibits metabolism of</span> <span>valproate</span> <span>(increased plasma concentration)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int904-zaleplon.htm">Zaleplon</a></td><td><p><span></span> <span>cimetidine</span> <span>inhibits metabolism of</span> <span>zaleplon</span> <span>(increased plasma concentration)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int575-zolmitriptan.htm">Zolmitriptan</a></td><td><p><span></span> <span>cimetidine</span> <span>inhibits metabolism of</span> <span>zolmitriptan</span> <span>(reduce dose of <span>zolmitriptan</span>)</span>  </p></td><td></td></tr></tbody></table><p><strong>Famotidine</strong> belongs to <strong>Histamine H<sub>2</sub>-antagonists</strong> and has the following interaction information:</p><table summary="Drug interactions" width="100%" border="0" cellspacing="2"><colgroup><col width="30%" class="cAG" /><col width="40%" class="cAF" /><col width="30%" class="cAH" /></colgroup><tbody><tr><td><a href="bnf_int1077-dasatinib.htm">Dasatinib</a></td><td><p><span></span> <span>famotidine</span> <span>possibly reduces plasma concentration of</span> <span>dasatinib</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int1048-erlotinib.htm">Erlotinib</a></td><td class="cAI"><p><span>avoidance of </span> <span>famotidine</span> <span>advised by manufacturer of</span> <span>erlotinib</span> <span></span>  </p></td><td></td></tr></tbody></table><p><strong>Nizatidine</strong> belongs to <strong>Histamine H<sub>2</sub>-antagonists</strong> and has the following interaction information:</p><table summary="Drug interactions" width="100%" border="0" cellspacing="2"><colgroup><col width="30%" class="cAG" /><col width="40%" class="cAF" /><col width="30%" class="cAH" /></colgroup><tbody><tr><td><a href="bnf_int1048-erlotinib.htm">Erlotinib</a></td><td class="cAI"><p><span>avoidance of </span> <span>nizatidine</span> <span>advised by manufacturer of</span> <span>erlotinib</span> <span></span>  </p></td><td></td></tr></tbody></table><p><strong>Ranitidine</strong> belongs to <strong>Histamine H<sub>2</sub>-antagonists</strong> and has the following interaction information:</p><table summary="Drug interactions" width="100%" border="0" cellspacing="2"><colgroup><col width="30%" class="cAG" /><col width="40%" class="cAF" /><col width="30%" class="cAH" /></colgroup><tbody><tr><td><a href="bnf_int1048-erlotinib.htm">Erlotinib</a></td><td class="cAI"><p><span></span> <span>ranitidine</span> <span>reduces plasma concentration of</span> <span>erlotinib</span> <span>—manufacturer of <span>erlotinib</span> advises give at least 2 hours before or 10 hours after <span>ranitidine</span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int1170-gefitinib.htm">Gefitinib</a></td><td class="cAI"><p><span></span> <span>ranitidine</span> <span>reduces plasma concentration of</span> <span>gefitinib</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int1027-tolazoline.htm">Tolazoline</a></td><td class="cAI"><p><span></span> <span>ranitidine</span> <span>antagonises effects of</span> <span>tolazoline</span> <span></span>  </p></td><td></td></tr></tbody></table></div><div id="pS"><p>Sub-sections</p><ul class="jT"><li><a href="bnf_int744-cimetidine.htm" title="Cimetidine">Cimetidine</a></li><li><a href="bnf_int745-famotidine.htm" title="Famotidine">Famotidine</a></li><li><a href="bnf_int746-nizatidine.htm" title="Nizatidine">Nizatidine</a></li><li><a href="bnf_int747-ranitidine.htm" title="Ranitidine">Ranitidine</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="bnf_int741-ulcer-healing-drugs.htm">Previous: Ulcer-healing Drugs</a> | <a class="top" href="bnf_int743-histamine-h-2-antagonists.htm#">Top</a> | <a accesskey="]" href="bnf_int744-cimetidine.htm">Next: Cimetidine</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>